Barriers | N (%) |
---|---|
Cultural difference | 20 (34.5) |
Lack of communication platform | 19 (32.8) |
Lack of e-trade platform | 11 (19.0) |
Lack of funds | 10 (17.2) |
Drug quality and certification issues | 10 (17.2) |
Complex application procedure | 8 (13.8) |
Lack of government support | 7 (12.1) |
The stability of the policy environment | 4 (6.9) |
Legal challenge | 4 (6.9) |
Others | 3 (5.2) |